|
FAM3D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.72040168169951E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.521599952933E-09 |
| Normal-vs-Stage2 |
1.378250E-03 |
| Normal-vs-Stage3 |
6.957300E-04 |
| Normal-vs-Stage4 |
6.956300E-02 |
| Stage1-vs-Stage2 |
1.146030E-01 |
| Stage1-vs-Stage3 |
1.595610E-01 |
| Stage1-vs-Stage4 |
5.856000E-01 |
| Stage2-vs-Stage3 |
8.808400E-01 |
| Stage2-vs-Stage4 |
7.331800E-01 |
| Stage3-vs-Stage4 |
7.973200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.35969959922522E-10 |
| Normal-vs-AfricanAmerican |
2.002800E-01 |
| Normal-vs-Asian |
4.364600E-04 |
| Caucasian-vs-AfricanAmerican |
7.925400E-01 |
| Caucasian-vs-Asian |
8.068000E-01 |
| AfricanAmerican-vs-Asian |
7.438800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.405800E-04 |
| Normal-vs-Female |
1.43460021639896E-10 |
| Male-vs-Female |
3.062800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.87390000000654E-05 |
| Normal-vs-Age(41-60Yrs) |
1.69660000004512E-06 |
| Normal-vs-Age(61-80Yrs) |
1.217490E-03 |
| Normal-vs-Age(81-100Yrs) |
8.751600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.718400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.119400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.238200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.639400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.735900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.225570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.218440E-03 |
| Classical-VS-Follicular |
1.166150E-02 |
| Classical-VS-Other |
2.256000E-01 |
| Classical-VS-Normal |
9.6970000029728E-08 |
| Tall-VS-Follicular |
1.382850E-04 |
| Tall-VS-Other |
1.132560E-01 |
| Tall-VS-Normal |
4.808200E-01 |
| Follicular-VS-Other |
9.021000E-01 |
| Follicular-VS-Normal |
2.39199999999551E-05 |
| Other-VS-Normal |
8.996300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.74600000702708E-09 |
| Normal-vs-N1 |
1.217410E-03 |
| N0-vs-N1 |
3.351700E-02 |
|
|
